NCT07653048 Personality Traits and Biochemical Risk Phenotypes
| NCT ID | NCT07653048 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical Center TOPMED |
| Condition | Prediabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-10-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study investigates the association between personality traits and routine laboratory abnormalities in adults undergoing routine health assessment. Personality traits are assessed using the Five-Factor Personality Inventory (FFPI), while biochemical data are obtained from routine laboratory testing, including markers of glycemic status, liver function, lipid metabolism, renal function, and complete blood count parameters. The primary objective of the study is to evaluate the association between FFPI personality trait scores and the total number of laboratory abnormalities identified during routine clinical evaluation. Secondary analyses will examine associations between personality traits and glycemic status, fasting plasma glucose concentration, liver function markers, lipid profile parameters, renal function indicators, complete blood count parameters, and the total number of laboratory abnormalities. The findings may contribute to a better understanding of the relationship between psychological characteristics and biological health indicators and may support the development of more personalized approaches to health promotion, risk assessment, and disease prevention.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older * Undergoing routine health assessment * Completion of the Five-Factor Personality Inventory (FFPI) * Availability of routine laboratory test results * Provision of written informed consent Exclusion Criteria: * Age younger than 18 years * Incomplete FFPI assessment * Missing or incomplete laboratory data * Refusal or inability to provide informed consent
Contact & Investigator
Stefania Diana St Nilca, Principal Psychologist, PhD St
PRINCIPAL INVESTIGATOR
George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș
Frequently Asked Questions
Who can join the NCT07653048 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Prediabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07653048 currently recruiting?
Yes, NCT07653048 is actively recruiting participants. Contact the research team at diana.nilca@umfst.ro for enrollment information.
Where is the NCT07653048 trial being conducted?
This trial is being conducted at Târgu Mureş, Romania.
Who is sponsoring the NCT07653048 clinical trial?
NCT07653048 is sponsored by Medical Center TOPMED. The principal investigator is Stefania Diana St Nilca, Principal Psychologist, PhD St at George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.